NATO DIANA Human performance and biotechnology Companies
Companies selected under the Human Health & Performance (2025) and Human Resilience & Biotechnology (2026) challenge areas.
28 tracked company records sit in this theme, 10.2% of the 275 records in the dataset, spread across 8 countries and 2 selection rounds. The theme is a tracker classification, not an official NATO category.
Challenge areas in this theme
| Challenge area | Companies | Share | Relative size |
|---|---|---|---|
| Human Resilience & Biotechnology | 15 | 53.6% | |
| Human Health & Performance | 13 | 46.4% |
By cohort
By country
| Country | Companies | Share | Relative size |
|---|---|---|---|
| United Kingdom | 6 | 22.2% | |
| Canada | 5 | 18.5% | |
| United States | 5 | 18.5% | |
| France | 4 | 14.8% | |
| Germany | 3 | 11.1% | |
| Netherlands | 2 | 7.4% | |
| Finland | 1 | 3.7% | |
| Türkiye | 1 | 3.7% |
Every company in this theme
Showing 1-25 of 28 company records. Filters are not indexed and do not change this page's address.
| Funding | Record status | ||||
|---|---|---|---|---|---|
| 52 North Health | United Kingdom | 2025 | Human Health & Performance | €100,000 non-dilutive grant + €300,000 Phase 2 funding | Verified against official source |
| Aboa Space Research Oy | Finland | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Publicly reported |
| AUXSYS | Germany | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Avivo Biomedical Inc. | Canada | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Belmont Diagnostics SAS | France | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| Beyond Blood Diagnostics | United Kingdom | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Publicly reported |
| Biocellis | France | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Cogitat | United Kingdom | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| Cohesys | Canada | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Deep Breathe Inc. | Canada | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Elitac Wearables | Netherlands | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Flosonics Medical | Canada | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| Gamma Pulse | France | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| GutSee Health | United Kingdom | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Publicly reported |
| Herges Detection GmbH | Germany | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Publicly reported |
| Hourglass Medical | United States | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Interact Medical Technologies | Türkiye | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| LightOx | United Kingdom | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Verified against official source |
| Lysando Innovations Lab GmbH | Germany | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Publicly reported |
| MANITTY | France | 2025 | Human Health & Performance | €100,000 non-dilutive grant + €300,000 Phase 2 funding | Verified against official source |
| Neuroverse | United States | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| New Platelet Company (NPC) | United Kingdom | 2026 | Human Resilience & Biotechnology | €100,000 non-dilutive grant | Publicly reported |
| Qidni Labs Inc. | Canada | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| QurieGen | Netherlands | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
| RealNose Inc | United States | 2025 | Human Health & Performance | €100,000 non-dilutive grant | Verified against official source |
Other technology themes
Methodology and limitations
Membership of this theme is derived from the official DIANA challenge area each company was selected under, so it follows NATO's own published grouping. No company is added on the basis of marketing material.
Themes overlap: a company can appear under more than one theme, so theme totals sum to more than the 275 tracked records. Where a company's technology is not described publicly, no theme is assigned rather than a guess.
Alliance Tech Tracker is independent and unofficial and is not affiliated with or endorsed by NATO or DIANA. Where a value is not published, records show "Not publicly available" rather than an estimate. See the full methodology.
Sources
Dataset version 2026.08 · data as of August 2026 · last reviewed 2026-08-23 · explore or download the full dataset